United Kingdom· GB-APID-36457111000001101
Renapime 2g powder for solution for injection vials
A cefepime product containing cefepime, registered in United Kingdom by Renascience Pharma Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Cefepime is registered in 17 of 19 countries.
Countries holding a registration under ATC J01DE01 (cefepime), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Cefepime · ATC J01DE01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefepime costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefepime · price per daily dose (4 g)
USD · FX 28 Sept 2026
- ES Spain$33.20
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cefepime
- Manufacturer
- Renascience Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01DE01
- ATC class
- Cefepime
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060512180015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
189 interactions on record for cefepime.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefepime · interactions on record
189 records
- 19 moderate
- 170 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefepime in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatescefepimeSagent Pharmaceuticals
- BelgiumCefepim Fresenius Kabi 1 gFresenius Kabi
- CzechiaCEFEPIM MIPMIP Pharma GmbH, Blieskastel
- SpainCEFEPIMA ACCORD 1 g POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- FranceAXEPIM 0,5 g, poudre pour solution injectableBRISTOL MYERS SQUIBB
- PolandCefepim MIP PharmaMIP Pharma GmbH
- NetherlandsCefepim Fresenius Kabi 1 g, poeder voor oplossing voor injectie of infusieFresenius Kabi Nederland B.V.
- GermanyCefepim AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Cefepim Aptapharma, Cefepim Mip
- Belgium · Cefepim Fresenius Kabi, Céfépime Ldp-Laboratorios Torlan
- Bulgaria · Алфацеф, Бактерипим
- Cyprus · Cefepim Noridem, Cefepime Aptapharma
- Czechia · Cefepim Mip, Cefepim Noridem
- Germany · Cefepim Accord, Cefepim Mip
- Denmark · Cefepim Mip
- Estonia · Alphacef, Cefepime Mip
- Spain · Cefepima Kabi, Cefepima Ldp-Laboratorios Torlan
- Finland · Cefepim Mip Pharma
- France · Cefepime Accord, Cefepime Noridem
- Greece · Anticepim, Cefepime /Kabi
- Croatia · Cefepim Aptapharma, Cefepime Kabi
- Hungary · Cefepim Aptapharma, Cefepim Noridem
- Italy · Cefepime Noridem, Cefepime Qilu
- Lithuania · Cefepime Mip, Cefepime Norameda
- Luxembourg · Cefepime Noridem
- Latvia · Cefepime Mip, Cefepime Norameda
- Malta · Cefepime Aptapharma
- Netherlands · Cefepim Fresenius Kabi, Cefepim Noridem
- Norway · Cefepim Mip
- Poland · Cefepim Mip Pharma, Cefepime Aptapharma
- Portugal · Cefepima Accord, Cefepima Basi
- Romania · Cefepimă Aptapharma, Cefepimă Mip
- Sweden · Cefepim Mip
- Slovenia · Cefepim Aptapharma, Cefepim Kabi
- Slovakia · Cefepim Mip, Cefepím Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9d613c6-e41a-4898-9253-cfb5853ca1cb GET /v1/drugs/f9d613c6-e41a-4898-9253-cfb5853ca1cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36457111000001101",
"desc": "Renapime 2g powder for solution for injection vials (Renascience Pharma Ltd)",
"form": "Powder for solution for injection",
"vpid": "36458511000001109",
"source": "dmd",
"vtm_id": "775095001",
"strength": "2 gram",
"substance": "Cefepime",
"ingredient": "Cefepime dihydrochloride monohydrate",
"supplier_code": "36445211000001101"
}See everything about cefepime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.